167 related articles for article (PubMed ID: 30405853)
1. Multiplex Cell-Free DNA Reference Materials for Quality Control of Next-Generation Sequencing-Based
Liu D; Zhang X; Zhou H; Lin X; Shi D; Shen S; Tian Y; Du B; Zhang H; Wang H; Wang Y; Zhang C
J Cancer; 2018; 9(20):3812-3823. PubMed ID: 30405853
[No Abstract] [Full Text] [Related]
2. Quality Control of Next-generation Sequencing-based
Liu D; Zhou H; Shi D; Shen S; Tian Y; Wang L; Lou J; Cong R; Lu J; Zhang H; Zhao M; Zhu S; Cao Z; Jin R; Wang Y; Zhang X; Yang G; Wang Y; Zhang C
J Cancer; 2018; 9(9):1680-1688. PubMed ID: 29760807
[No Abstract] [Full Text] [Related]
3. Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients.
Xu X; Huang F; Cao M; Chen X; Wang H; Jiang H; Yu Y; Shen M; Yang Y; Wang B; Liu T; Guo W
J Clin Lab Anal; 2021 Sep; 35(9):e23818. PubMed ID: 34403504
[TBL] [Abstract][Full Text] [Related]
4. Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients.
Wang B; Wu S; Huang F; Shen M; Jiang H; Yu Y; Yu Q; Yang Y; Zhao Y; Zhou Y; Pan B; Liu T; Guo W
Clin Chem Lab Med; 2019 Sep; 57(10):1501-1510. PubMed ID: 31339850
[TBL] [Abstract][Full Text] [Related]
5. Rapid Somatic Mutation Testing in Colorectal Cancer by Use of a Fully Automated System and Single-Use Cartridge: A Comparison with Next-Generation Sequencing.
Al-Turkmani MR; Godwin KN; Peterson JD; Tsongalis GJ
J Appl Lab Med; 2018 Sep; 3(2):178-184. PubMed ID: 33636938
[TBL] [Abstract][Full Text] [Related]
6. Construction of a reference material panel for detecting
Xu J; Qu S; Sun N; Zhang W; Zhang J; Song Q; Lin M; Gao W; Zheng Q; Han M; Na C; Xu R; Chang X; Yang X; Huang J
J Clin Pathol; 2021 May; 74(5):314-320. PubMed ID: 32817175
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-associated clonal hematopoiesis mutations should be taken seriously in plasma cell-free DNA KRAS/NRAS/BRAF genotyping for metastatic colorectal cancer.
Huang F; Yang Y; Chen X; Jiang H; Wang H; Shen M; Yu Y; Liu T; Pan B; Wang B; Guo W
Clin Biochem; 2021 Jun; 92():46-53. PubMed ID: 33737000
[TBL] [Abstract][Full Text] [Related]
8. Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors.
Mehrotra M; Singh RR; Loghavi S; Duose DY; Barkoh BA; Behrens C; Patel KP; Routbort MJ; Kopetz S; Broaddus RR; Medeiros LJ; Wistuba II; Luthra R
Oncotarget; 2018 Feb; 9(12):10259-10271. PubMed ID: 29535804
[TBL] [Abstract][Full Text] [Related]
9. Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing.
Demuth C; Spindler KG; Johansen JS; Pallisgaard N; Nielsen D; Hogdall E; Vittrup B; Sorensen BS
Transl Oncol; 2018 Oct; 11(5):1220-1224. PubMed ID: 30086420
[TBL] [Abstract][Full Text] [Related]
10. An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.
Ono Y; Sugitani A; Karasaki H; Ogata M; Nozaki R; Sasajima J; Yokochi T; Asahara S; Koizumi K; Ando K; Hironaka K; Daito T; Mizukami Y
Mol Oncol; 2017 Oct; 11(10):1448-1458. PubMed ID: 28691390
[TBL] [Abstract][Full Text] [Related]
11. Multiplex detection of ctDNA mutations in plasma of colorectal cancer patients by PCR/SERS assay.
Lyu N; Rajendran VK; Diefenbach RJ; Charles K; Clarke SJ; Engel A; ; Rizos H; Molloy MP; Wang Y
Nanotheranostics; 2020; 4(4):224-232. PubMed ID: 32923312
[TBL] [Abstract][Full Text] [Related]
12. Detection of Somatic Mutations with ddPCR from Liquid Biopsy of Colorectal Cancer Patients.
Zmrzljak UP; Košir R; Krivokapić Z; Radojković D; Nikolić A
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33669856
[TBL] [Abstract][Full Text] [Related]
13. Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers.
Möhrmann L; Huang HJ; Hong DS; Tsimberidou AM; Fu S; Piha-Paul SA; Subbiah V; Karp DD; Naing A; Krug A; Enderle D; Priewasser T; Noerholm M; Eitan E; Coticchia C; Stoll G; Jordan LM; Eng C; Kopetz ES; Skog J; Meric-Bernstam F; Janku F
Clin Cancer Res; 2018 Jan; 24(1):181-188. PubMed ID: 29051321
[No Abstract] [Full Text] [Related]
14. Plasma next generation sequencing and droplet digital PCR-based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent-line osimertinib.
Ding PN; Becker T; Bray V; Chua W; Ma Y; Xu B; Lynch D; de Souza P; Roberts T
Thorac Cancer; 2019 Oct; 10(10):1879-1884. PubMed ID: 31414729
[TBL] [Abstract][Full Text] [Related]
15. Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study.
Smyth LM; Reichel JB; Tang J; Patel JAA; Meng F; Selcuklu DS; Houck-Loomis B; You D; Samoila A; Schiavon G; Li BT; Razavi P; Piscuoglio S; Reis-Filho JS; Taylor BS; Baselga J; Solit DB; Hyman DM; Berger MF; Chandarlapaty S
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250397
[TBL] [Abstract][Full Text] [Related]
16. Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy).
Garcia J; Forestier J; Dusserre E; Wozny AS; Geiguer F; Merle P; Tissot C; Ferraro-Peyret C; Jones FS; Edelstein DL; Cheynet V; Bardel C; Vilchez G; Xu Z; Bringuier PP; Barritault M; Brengle-Pesce K; Guillet M; Chauvenet M; Manship B; Brevet M; Rodriguez-Lafrasse C; Hervieu V; Couraud S; Walter T; Payen L
Oncotarget; 2018 Apr; 9(30):21122-21131. PubMed ID: 29765524
[TBL] [Abstract][Full Text] [Related]
17. Highly sensitive detection of ESR1 mutations in cell-free DNA from patients with metastatic breast cancer using molecular barcode sequencing.
Masunaga N; Kagara N; Motooka D; Nakamura S; Miyake T; Tanei T; Naoi Y; Shimoda M; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2018 Jan; 167(1):49-58. PubMed ID: 28905136
[TBL] [Abstract][Full Text] [Related]
18. Detection of mutations in circulating cell-free DNA in relation to disease stage in colorectal cancer.
Liebs S; Keilholz U; Kehler I; Schweiger C; Haybäck J; Nonnenmacher A
Cancer Med; 2019 Jul; 8(8):3761-3769. PubMed ID: 31134762
[TBL] [Abstract][Full Text] [Related]
19. Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction.
Janku F; Huang HJ; Fujii T; Shelton DN; Madwani K; Fu S; Tsimberidou AM; Piha-Paul SA; Wheler JJ; Zinner RG; Naing A; Hong DS; Karp DD; Cabrilo G; Kopetz ES; Subbiah V; Luthra R; Kee BK; Eng C; Morris VK; Karlin-Neumann GA; Meric-Bernstam F
Ann Oncol; 2017 Mar; 28(3):642-650. PubMed ID: 27993791
[TBL] [Abstract][Full Text] [Related]
20. Fractionated small cell-free DNA increases possibility to detect cancer-related gene mutations in advanced colorectal cancer.
Ishida Y; Takano S; Maekawa S; Yamaguchi T; Yoshida T; Kobayashi S; Iwamoto F; Kuno T; Hayakawa H; Matsuda S; Fukasawa M; Shindo H; Inoue T; Nakayama Y; Ichikawa D; Sato T; Enomoto N
JGH Open; 2020 Oct; 4(5):978-986. PubMed ID: 33102773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
